Bone mineral density and bone markers in hypogonadotropic and hypergonadotropic hypogonadal men after prolonged testosterone treatment

Journal of Endocrinological Investigation

Volumn 24, Issue 4, 2001, Pages 246-252

  De Rosa, Michele ^a,b   Paesano, L ^a   Nuzzo, V ^a   Zarrilli, S ^a   Del Puente, A ^a   Oriente, P ^a   Lupoli, G ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b NONE   (Italy)

Author keywords

Bone markers; Bone mineral density; Bone turnover; Hypogonadism; Klinefelter's syndrome; Osteopenia; Osteoporosis; Testosterone therapy

Indexed keywords

ALKALINE PHOSPHATASE BONE ISOENZYME; BIOLOGICAL MARKER; COLLAGEN TYPE 1; CREATININE; OSTEOCALCIN; PEPTIDE DERIVATIVE; TESTOSTERONE ENANTATE;

ADULT; AGE; ARTICLE; BODY DENSITY; BODY HEIGHT; BODY MASS; BODY WEIGHT; BONE ATROPHY; BONE METABOLISM; CLINICAL ARTICLE; CLINICAL FEATURE; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION FUNCTION; DISEASE SEVERITY; EARLY DIAGNOSIS; EVALUATION; FEMUR NECK; HORMONAL THERAPY; HORMONE BLOOD LEVEL; HUMAN; HYPERGONADOTROPIC HYPOGONADISM; HYPOGONADISM; IDIOPATHIC DISEASE; KLINEFELTER SYNDROME; LONG TERM EXPOSURE; LUMBAR SPINE; MALE; MEDICAL EXAMINATION; MORBIDITY; OSSIFICATION; OSTEOLYSIS; OSTEOPENIA; OSTEOPOROSIS;

EID: 0035033243     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03343854     Document Type: Article

References (24)

1. Seeman E., Melton L.J., O'Fallon W.M., Riggs B.L. Risk factors for spinal osteoporosis in men. Am. J. Med. 1983, 75: 977-983.
2. Jackson J.A., Kleerekoper M. Osteoporosis in men: diagnosis, pathophysiology, and prevention. Medicine 1990, 69: 137-152.
3. Colvard D.S., Erikson E.F., Keeting P.E., Wilson E.M., Lubahn D.B., French F.S., Riggs B.L., Spelsberg T.C. Identification of androgen receptors in normal human osteoblast-like cells. Proc. Natl. Acad. Sci. USA 1989, 86: 854-857.
4. Orwoll E.S., Stribrska L., Ramsey E.E., Keenan E.J. Androgen receptors in osteoblast-like cell lines. Calcif. Tissue Int. 1991, 49: 183-187.
5. Kasperk C.H., Wergedal J.E., Farkey J.R., Linkhart T.A., Turner R.T., Baylink D.J. Androgens directly stimulate proliferation of bone cells in vitro. Endocrinology 1989, 124: 1576-1578.
6. Baran D.T., Bergfeld M.A., Teitelbaum S.L., Avioli L.V. Effect of testosterone therapy on bone formation in an osteoporotic hypogonadal male. Calcif. Tissue Res. 1978, 26: 103-106.
7. Crilly R.G., Francis R.M., Nordin B.E.C. Steroid hormones, ageing and bone. J. Clin. Endocrinol. Metab. 1989, 10: 115-139.
8. Smith E.P., Boyd J., Frank G.R., Takahashi H., Cohen R.M., Specker B., Williams T.C., Lubahn D.B., Korach K.S. Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. N. Engl. J. Med. 1994, 331: 1056-1061.
9. Horowitz M., Wishart J.M., O'Loughlin P.D., Morris H.A., Need A.G., Nordin B.E.C. Osteoporosis and Klinefelter's syndrome. Clin. Endocrinol. (Oxf.) 1992, 36: 113-118.
10. Favus M.J. Bone density reference data. In: Favus M.J. (Ed.), Primer on the metabolic bone diseases and disorders of mineral metabolism, ed 2. Raven Press, New York, 1993, p. 426.
11. Finkelstein J.S., Klibanski A., Neer R.M., Greenspan S.L., Rosenthal D.I., Crowley W.F. Osteoporosis in men with idiopathic hypogonadotropic hypogonadism. Ann. Intern. Med. 1987, 106: 354-361.
12. Canale D., Vignali E., Golia F., Martino E., Pinchera A., Marcocci C. Effects of hormonal replacement treatment on bone mineral density and metabolism in hypogonadal patients. Mol. Cell. Endocrinol. 2000, 161: 47-51.
13. Guo C.Y., Jones T.H., Eastell R. Treatment of isolated hypogonadotropic hypogonadism effect on bone mineral density and bone turnover. J. Clin. Endocrinol. Metab. 1997, 82: 658-665.
14. Wong H.W., Pun K.K., Wang C. Loss of bone mass in patients with Klinefelter's syndrome despite sufficient testosterone replacement. Osteoporos. Int. 1993, 3: 3-7.
15. Cantrill J.A., Denis P., Large D.M., Neuman M., Anderson D.C. Which testosterone replacement therapy. Clin. Endocrinol. (Oxf.) 1984, 27: 97-107.
16. Behre H.M., Kliesch S., Leifke E., Link T.M., Nieschlag E. Long-term effect of testosterone therapy on bone mineral density in hypogonadal men. J. Clin. Endocrinol. Metab. 1997, 82: 2386-2390.
17. Katznelson L., Finkelstein J.S., Schoenfeld D.A., Rosenthal D.I., Anderson E.J., Klibanski A. Increase in bone density and lean body mass during testosterone administration in men with acquired hypogonadism. J. Clin. Endocrinol. Metab. 1996, 81: 4358-4365.
18. Scane A.C., Francis R.M. Risk factors for osteoporosis in men. Clin. Endocrinol. (Oxf.) 1993, 38: 15-16.
19. Finkelstein J.S., Klibanski A., Neer R.M., Doppelt S.H., Rosenthal D.I., Segre G.V., Crowley W.F. Increases in bone density during treatment of men with idiopathic hypogonadotropic hypogonadism. J. Clin. Endocrinol. Metab. 1989, 69: 776-783.
20. Finkelstein J.S., Klibanski A., Neer R.M. A longitudinal evaluation of bone mineral density in adult men with histories of delayed puberty. J. Clin. Endocrinol. Metab. 1996, 81: 1152-1155.
21. Bardin C.W., Swerdloff R.S., Santen R.J. Androgens: risks and benefits. J. Clin. Endocrinol. Metab. 1991, 73: 4-7.
22. Luisetto G., Mastrogiacomo I., Bonanni G., Pozzan G., Botteon S., Tizian L., Galuppo P. Bone mass and mineral metabolism in Klinefelter's syndrome. Osteoporos. Int. 1995, 5: 455-461.
23. Foresta C., Ruzza G., Mioni R., Meneghello A., Baccichetti C. Testosterone and bone loss in Klinefelter's syndrome. Norm. Metab. Res. 1983, 15: 56-57.
24. Choi H.R., Lim S.K., Lee M.S. Site-specific effect of testosterone on bone mineral density in male hypogonadism. J. Korean Med. Sci. 1995, 10: 431-435.